Long-term Outcomes after HCV SVR | Room 716

Saturday, June 16, 2018
2:00 PM to 3:45 PM

Chairs: Ray Kim & Bettina Hansen

Invited Presentations:

2:00pm
How do we prove HCV SVR improves HCC, liver failure and mortality?
Adriaan Van der Meer, Erasmus University Rotterdam, Berkel en Rodenrijs

2:25pm
Extrahepatic benefits of SVR in HCV infection
Michael Fried, University of North Carolina, North Carolina

2:50pm
Will liver transplant disappear for HCV infection?
Graham Foster, Queen Marys University Of London, London

Oral Abstracts:

3:15pm
Comparison of event-free survival between DAA and IFN-based antiviral therapy for HCV, adjusted for disease severity
Lisette Krassenburg, University Health Network, Toronto

3:30pm
Genotype 5 HCV – patient characteristics, resistance mutations and treatment outcomes
Mark W. Sonderup, University Of Cape Town, Cape Town

Return to Schedule